Stay updated on the latest developments in the GLP-1 drug class, including a new generic entering the market, weight loss results, FDA decisions & cost issues.

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

After about 10 months of being on Ozempic and working my way up to a 1-milligram dose, I lost 40 pounds effortlessly.

Eli Lilly and Novo Nordisk are likely to introduce its popular injectable drugs semaglutide and tirzepatide in India in 2025.

The small miracles that 2024 brought to our lives lay the groundwork for new revolutionary treatments that are being prepared ...

StudyFinds' Dr. Faith Colemans explains why shopping for weight loss drugs online may save you money but endanger your health ...

The third ‘Downton Abbey’ film honors the late Dame Maggie Smith and her iconic portrayal of Violet Crawley. The drug is ...

They initially lost 40 pounds effortlessly, but now the weight is returning and so are the craving for sweets.

The year had a lot to offer, from advanced therapies aimed at Lp(a), GLP-1, and other targets, to support for simpler ...

In a new study, an experimental obesity drug from Novo Nordisk called CagriSema allowed people to lose more than 20% of their ...

Increase public health subsidy ratio, minimum guarantee for village doctors to 3,500 yuan Merck acquires AmpTec Eli Lilly's tirzepatide head-to-head Phase III study successfully demonstrated superior ...

INR:4077. bet365 europe Amgen's KRAS G12C inhibitor successfully treats advanced non-small cell lung cancer in Phase II study Is Qianjin Pharmaceutical's use of the ...